Similar Papers

Paper Title
Journal
Date
Author
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study.
Liangliang Wang ... Yu Qin
Journal of gynecologic oncology | VOL. 34
Liangliang Wang, et. al.Liangliang Wang ... Yu Qin
01 Jan 2023
First-line chemotherapy for ovarian cancer - the controversy continues.
S B Kaye
British Journal of Cancer | VOL. 87
S B KayeS B Kaye
01 Oct 2002
Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns)
Vanessa L Beesley ... Michael L Friedlander
Gynecologic Oncology | VOL. 164
Vanessa L Beesley, et. al.Vanessa L Beesley ... Michael L Friedlander
24 Dec 2021
The Significance of Combination Chemotherapy in Epithelial Ovarian Cancer
Janice S Kwon ... Kenneth Swenerton
International Journal of Gynecologic Cancer | VOL. 24
Janice S Kwon, et. al.Janice S Kwon ... Kenneth Swenerton
01 Feb 2014
View more papers

More From: Journal of the National Cancer Center

Paper Title
Journal
Date
Author
Potential reduction of global colorectal cancer, 1990-2021
Zilin Luo ... Ni Li
Journal of the National Cancer Center | VOL. -
Zilin Luo, et. al.Zilin Luo ... Ni Li
01 Jan 2025
Three-field vs two-field lymphadenectomy in thoracic ESCC patients: a multicenter randomized study (NST 1503)
Yousheng Mao ... Jie He
Journal of the National Cancer Center | VOL. -
Yousheng Mao, et. al.Yousheng Mao ... Jie He
01 Jan 2025
The value of PFS36 as a primary endpoint for radiotherapy trials in patients with LACC: individual patient data from the Chinese NCC and validation from 26 RCTs
Xi Yang ... Manni Huang
Journal of the National Cancer Center | VOL. -
Xi Yang, et. al.Xi Yang ... Manni Huang
01 Jan 2025
Corrigendum to ‘Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial’ [Journal of the National Cancer Center 4 (2024) 135–141
Rong Li ... Qi Zhou
Journal of the National Cancer Center | VOL. -
Rong Li, et. al.Rong Li ... Qi Zhou
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.